Diamyd Medical confirms key advances toward Accelerated Approval for Diamyd® following FDA Type C Meeting

STOCKHOLM, Jan. 10, 2025 /PRNewswire/ — Diamyd Medical provides an update following the receipt of final meeting minutes from a positive Type C meeting with the U.S. Food and Drug Administration (FDA) held in December 2024. The meeting focused on refining study protocol and analysis…